What we can learn from the virus debate.

Under the title: "La Ola - was that the "perfect" wave?" our management consultant Dr. Ralf Hess gave an interview to the UNIversalis newspaper.
Munich, August 3, 2020.

Under the title: "La Ola - was that the "perfect" wave?" our management consultant Dr. Ralf Hess gave an interview to the UNIversalis newspaper.

In an interview with the UNIversalis newspaper, virologist and immunologist Dr. Ralf Hess provides information on the current status of the corona situation in Germany. He talks about economic consequences and how the population should behave. But he also talks about what a virus is, how it is transmitted to humans. How a vaccine is developed and whether we are facing a second wave or not.

At the following link you can find the article.

Read here.

Share Article.

Facebook
Twitter
LinkedIn
XING
WhatsApp
Email

Persons to the article.

Dr Ralf Hess

Principal Consultant IVD

Dr. Ralf Hess studied biology at the Albert-Ludwigs-University of Freiburg, where he also completed his doctorate at the Institute of Virology. Dr. Hess has many years of experience in the development of medical devices and medicinal products and their combination, in laboratory analysis and quality assurance. The quality expert has set up, implemented and maintained QM systems in accordance with ISO and GxP for various areas of application. The customer service portfolio ranges from manufacturers of classical and biological drugs, medical device companies and vaccine manufacturers to immunohistochemical, immunological, molecular biological and serological diagnostic laboratories. Dr. Hess works worldwide as an auditor in the GxP/ISO area and has many years of experience in FDA remediation projects and the regulatory development of combination products (drug device products).
Dr. Ralf Hess supports Entourage as Principal Consultant IVD.

Newsletter.

Read more.

The world is reacting. To the coronavirus pandemic. Blog post by Dr. Ralf Hess.
A biologist with a PhD and member of the Entourage Task Force, Dr. ...
How the Next Generation Supply Chain is emerging.
The next generation supply chain needs not only digital ...
Repurposing of drugs against SARS-CoV-2.
In addition to the development of new drugs against the coronavirus, ...
Qualitative content analysis to establish audit trail requirements.
The audit trail is laid down in regulatory requirements and guidelines ...
Drug Shortages in Germany - A Critical Assessment.
Dr. Ralf Hess, Dominik M. Aumer, Moritz Haucke and Dr. ...